“Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): 458-62. https://doi.org/10.25251/skin.6.6.2.